CORC  > 复旦大学上海医学院
Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30
Guo, Zhigui; Cao, Manqing; You, Abin; Gao, Junrong; Zhou, Hongyuan; Li, Huikai; Cui, Yunlong; Fang, Feng; Zhang, Wei; Song, Tianqiang
刊名CANCER SCIENCE
2016
卷号107期号:4
关键词Hepatocellular carcinoma human TIP30 protein metformin sorafenib thioredoxins
ISSN号1349-7006
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3625555
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Guo, Zhigui,Cao, Manqing,You, Abin,et al. Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30[J]. CANCER SCIENCE,2016,107(4).
APA Guo, Zhigui.,Cao, Manqing.,You, Abin.,Gao, Junrong.,Zhou, Hongyuan.,...&Zhang, Ti.(2016).Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30.CANCER SCIENCE,107(4).
MLA Guo, Zhigui,et al."Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30".CANCER SCIENCE 107.4(2016).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace